Abstract
Infectious mononucleosis (IM) is typically a self-limited lymphoprolifer-ation, i.e., an array of host responses normally brings to a natural halt the intense proliferation of B lymphocytes induced by Epstein-Barr virus (EBV) infection (Carter, 1975). That immune mechanisms are responsible for the control of EBV infection is clearly deduced from the observation that immunosuppressed patients, such as renal transplant recipients, manifest severe forms of IM as well as a spectrum of lymphoproliferative disorders associated with EBV (Hanto et ah, 1981). Similarly, an X-linked deficiency that appears to be specific for EBV underlies the unusually severe forms of IM observed in patients with X-linked lymphoproliferative (XLP) syndrome (Purtilo, 1976; Sullivan, this volume). Finally, abnormal antibody responses to EBV are observed in immunologically compromised individuals (Henle and Henle, 1981). Thus, the finding of an abnormal response to EBV, manifested by an unusually severe disease caused by EBV infection, should induce a search for an immunological defect. We have been looking systematically at EBV serology in a large series of patients with well-defined congenital immune deficiencies such as Chediak-Higashi or Wiskott-Aldrich syndrome. As discussed below, we found abnormal anti-EBV serological profiles in a number of patients, but, much to our surprise, we did not observe any severe form of IM in these patients. In contrast, we found severe IM in patients with no known primary or secondary immune deficiency detectable by classical tests, but with clear, permanent abnormalities of the interferon (IFN) system. In one case, IFN production by leukocytes was profoundly diminished. In other cases, IFN secretion was normal, but natural killer (NK) activity could not be enhanced by addition of IFN in vitro or IFN administration in vivo. Such observations are compatible with one hypothesis that IFN plays an important role in host defense against EBV infection. The aim of the present chapter is to describe clinical and immunological observations on patients with abnormal responses to EBV infection, and to discuss the possible role of endogenous production of IFN and of cytotoxic effectors of the IFN system in the control of EBV infection.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barr, R. S., Delow, J. C., Clausen, K. P., Hurtubise, P., Henle, W., and Hewetson, J. F., 1974, Fatal infectious mononucleosis in a family, N. Engl. J. Med. 290:363.
Britton, S., Andersson-Anvret, M., Gergely, P., Henle, W., Jondal, M., Klein, G., Sandstedt, B., and Svedmyr, E., 1978, Epstein-Barr virus immunity and tissue distribution in a fatal case of infectious mononucleosis, N. Engl. J. Med. 298:89.
Carter, R. L., 1975, Infectious mononucleosis: Model for self-limiting lymphoproliferation, Lancet 1:846.
Cheeseman, S. H., Henle, W., Rubin, R. H., Tolkoff, N. E., Cosimi, B., Cantell, K., Winkle, S., Herrin, J. T., Black, P. H., Russell, P. S., and Hirsch, N. S., 1980, Epstein-Barr virus infection in renal transplant recipients: Effects of antithymocyte globulin and interferon, Ann. Intern. Med. 93:39.
Crawford, D. H., Epstein, M. A., Achong, B. G., Finerty, S., Newman, J., Liversedge, S., Tedder, R. S., and Stewart, J. W., 1979, Virological and immunological studies on a fatal case of infectious mononucleosis, J. Infect. 1:37.
Fellous, M., Bono, R., Hyafil, F., and Gresser, I., 1981, Interferon enhances the amount of membrane-bound β2 microglobulin and its release from human Burkitt cells, Eur. J. Immunol. 11:524.
Fleisher, M. D., Starr, S., Koven, N., Kamiya, H., Douglas, S. D., and Henle, W., 1982, A non-X linked syndrome with susceptibility to severe Epstein-Barr virus infections, J. Pediatr. 100:727.
Hanto, D. W., Frizzera, G., Purtilo, D. T., Sakamoto, K., Sullivan, J. L., Saemundsen, A. K., Klein, G., Simmons, R. L., and Najarian, J. S., 1981, Clinical spectrum of lymphopro-liferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus, Cancer Res. 41:4253.
Harada, S., Bechtold, T., Seeley, J. K., and Purtilo, D. T., 1982, Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK) cell activity in the X-linked lympho-proliferative syndrome, Int. J. Cancer 30:739.
Hasler, F., Bluestein, H. G., Zvaifler, N. J., and Epstein, L. B., 1983, Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation, J. Exp. Med. 157:173.
Henle, W., and Henle, G., 1981, Epstein-Barr virus-specific serology in immunologically compromised individuals, Cancer Res. 41:4222.
Jondal, M., 1976, Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis, Clin. Exp. Immunol. 25:1.
Jondal, M., and Klein, G., 1973, Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes, J. Exp. Med. 138:1365.
Lai, P. K., Alpers, M. P., and MacKay-Scollay, E. M., 1977, Epstein-Barr virus infection: Inhibition by immunologically induced mediators with interferon-like properties, Int. J. Cancer 20:21.
Levin, M. J., Parkman, R., Oxman, M. N., Rappaport, J. M., Simpson, M., and Leary, D. L., 1978, Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans, Infect. Immun. 20:678.
Masucci, M. G., Klein, E., and Argov, S., 1980, Disappearance of the NK effect after ex-plantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures, J. Immunol. 124:2458.
Menazes, J., Patel, P., Dussault, H., Joncas, J., and Leibold, W., 1976, Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein-Barr virus, Nature 260:430.
Misko, I. S., Moss, D. J., and Pope, J. H., 1980, HLA-antigen related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus, Proc. Natl. Acad. Sci. USA 77:4247.
Moss, D. J., Scott, W., and Pope, J. H., 1977, An immunological basis for inhibition of transformation of human lymphocytes by EB virus, Nature 268:735.
Nonoyama, M., and Pagano, J. S., 1971, Detection of Epstein-Barr viral genome in nonproductive cells, Nature New Biol. 233:103.
Pattengale, P. K., Smith, R. W., and Gerber, P., 1973, Selective transformation of B lymphocytes by EB virus, Lancet 2:93.
Pearson, G. R., and Orr, T. W., 1976, Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigen, J. Natl. Cancer Inst. 56:485.
Purtilo, D. T., 1976, Pathogenesis and phenotypes of an X-linked recessive lymphoproli-ferative syndrome, Lancet 2:882.
Purtilo, D. T., Cassel, C., Yang, J. P. S., Stephenson, S. R., Harper, R., Landing, G. H., and Vawter, G. F., 1975, X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease), Lancet 1:935.
Purtilo, D. T., Sakamoto, K., Barnabel, K., Seeley, V., Bechtold, J., Rogers, G., Yetz, J., and Harald, S., 1982, Epstein-Barr virus induced diseases in boys with the X-linked lym-phoproliferative syndrome (XLP), Am. J. Med. 73:49.
Rickinson, A. B., Moss, D. J., and Pope, J. H., 1979, Long-term T cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leucocyte cultures, Int. J. Cancer 23:610.
Rickinson, A. B., Wallace, L. E., and Pope, J. H., 1980, HLA-restricted T cell recognition of Epstein-Barr virus-infected B cells, Nature 283:865.
Rickinson, A. B., Moss, D. J., Wallace, L. E., Rowe, M., Misko, J. S., Epstein, M. A., and Pope, J. H., 1981, Long-term T cell-mediated immunity to Epstein-Barr virus, Cancer Res. 41:4216.
Rytel, M. W., and Balay, J., 1973, Impaired production of interferon in lymphocytes from immunosuppressed patients, J. Infect. Dis. 127:445.
Sakamoto, K., Freed, H. J., and Purtilo, D. T., 1980, Antibody response to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome, J. Immunol. 125:921.
Seeley, J., Svedmyr, E., Weiland, O., Klein, G., Muller, E., Erichsson, E., Andersson, K., and Van der Waal, L., 1981, Epstein-Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens, J. Immunol. 127:293.
Stewart W. E., II (ed.), 1979, The Interferon System, Springer-Verlag, Berlin.
Sullivan, J. L., Byron, K. S., Brewster, F. E., and Purtilo, D. T., 1980, Deficient natural killer activity in X-linked lymphoproliferative syndrome, 210:543.
Svedmyr, E., and Jondal, M., 1975, Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis, Proc. Natl. Acad. Sci. USA 72:1622.
Takaki, K., Horado, M., Sairenji, T., and Hinuma, Y., 1980, Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome, J. Immunol. 125:2112.
Thestrup-Pedersen, K., Esmann, V., Jensen, J. R., Hastrup, J., Thorling, K., Saemundsen, A. K., Bisballe, S., Pallesen, G., Madsen, M., Masucci, M. G., and Ernberg, I., 1980, Epstein-Barr virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect, Lancet 2:997.
Thorley-Lawson, D. A., 1981, The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phyto-hemagglutinin is inhibited by interferon: The early suppression by T cells of Epstein-Barr infection is mediated by interferon, J. Immunol. 126:829.
Thorley-Lawson, D. A., Chess, L., and Strominger, J. L., 1977, Suppression of in vitro Epstein-Barr virus infection: A new role for adult human T lymphocytes, J. Exp. Med. 146:495.
Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M., 1979, Activation of suppressor T cells during Epstein-Barr virus-induced infectious mononucleosis, N. Engl. J. Med. 301:1133.
Vilmer, E., Lenoir, G. M. Virelizier, J. L., and Griscelli, C., 1984, Epstein-Barr serology in immunodeficiencies: An attempt to correlate to immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia-telengiectasia, Clin. Exp. Immunol. 55:249.
Virelizier, J. L., 1984a, Immunoregulatory effects of interferons and their therapeutic implications, in: Approaches to Antiviral Agents, Macmillan and Co., London, in press.
Virelizier, J. L., 1984b, Deficiencies of interferon production in children, Presse Med. 13:495.
Virelizier, J. L., and Griscelli, C., 1980, Interferon administration as an immunoregulatory and antimicrobial treatment in children with defective interferon secretion, in: Primary Immunodeficiencies (M. Seligmann and W. H. Hitzig, eds.), pp. 231–234, Elsev-ier/North-Holland, Amsterdam.
Virelizier, J. L., and Griscelli, C., 1981, Défaut sélectif de secretion d’interferon associe a un deficit d’activité cytotoxique naturelle, Arch. Fr. Pediatr. 38:77.
Virelizier, J. L., and Guy-Grand, D., 1980, Immune interferon secretion as an expression of immunological memory to transplantation antigens: In vivo generatin of long-lived, recirculating memory cells, Eur. J. Immunol. 10:375.
Virelizier, J. L., Lenoir, G., and Griscelli, C., 1978, Persistent Epstein-Barr virus infection in a child with hypergammaglobulinemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion, Lancet 2:231.
Virelizier, J. L., Perez, N., Arenzana-Seisdedos, F., and Devos, R., 1984, Pure IFN-enhances class II HLA-antigens on human monocyte cell lines, Eur. J. Immunol. 14:106.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Virelizier, JL. (1985). Abnormal Responses to EBV Infection in Patients with Impairment of the Interferon System. In: Roizman, B., Lopez, C. (eds) The Herpesviruses. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8021-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8021-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8023-2
Online ISBN: 978-1-4615-8021-8
eBook Packages: Springer Book Archive